Financhill
Sell
42

CGEM Quote, Financials, Valuation and Earnings

Last price:
$10.33
Seasonality move :
11%
Day range:
$9.61 - $10.14
52-week range:
$5.68 - $13.33
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.27x
Volume:
1.9M
Avg. volume:
1.3M
1-year change:
-11.6%
Market cap:
$571.9M
Revenue:
--
EPS (TTM):
-$3.68

Earnings Data

Next earnings date for CGEM
Feb 26
2026
Most recent earnings per share
-$0.86
Beat by $0.04
(Nov 6/2025)
Consensus Estimate
-$0.89
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CGEM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/26/2026 Q4 $6.3M -- -- -$0.81 --
11/06/2025 Q3 -- -- -$0.86 -$0.89 $0.04
08/08/2025 Q2 -- -- -$1.19 -$0.86 -$0.33
05/12/2025 Q1 -- -- -$0.82 -$0.81 -$0.01
02/27/2025 Q4 -- -- -$0.81 -$0.74 -$0.07
11/07/2024 Q3 -- -- -$0.70 -$0.77 $0.07
08/08/2024 Q2 -- -- -$0.76 -$0.73 -$0.03
05/15/2024 Q1 -- -- -$0.86 -$0.90 $0.04
03/14/2024 Q4 -- -- -$0.56 -$0.98 $0.42
11/08/2023 Q3 -- -- -$0.92 -- --
08/10/2023 Q2 -- -- -$0.81 -- --
05/11/2023 Q1 -- -- -$1.42 -- --
03/09/2023 Q4 -- -- -$0.59 -- --
11/14/2022 Q3 -- -- -$0.54 -- --
08/10/2022 Q2 -- -- $3.77 -- --
05/16/2022 Q1 -- -- -$0.27 -- --
03/17/2022 Q4 -- -- -$0.73 -- --
11/09/2021 Q3 -- -- -$0.40 -- --
08/10/2021 Q2 -- -- -$0.36 -- --
05/14/2021 Q1 -- $18.9M -$0.00 -- --
03/30/2021 Q4 -- -- -$0.65 -- --
09/30/2020 Q3 -- -- -$0.23 -- --
06/30/2020 Q2 -- -- -$0.20 -- --
03/31/2020 Q1 -- -- -$0.26 -- --
12/31/2019 Q4 -- -- -$0.11 -- --
09/30/2019 Q3 -- -- -$0.98 -- --

Cullinan Therapeutics, Inc. Earnings Questions

  • How Much did Cullinan Therapeutics, Inc. Generate in Revenue Last Quarter?

    Cullinan Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Cullinan Therapeutics, Inc. Beat Earnings Last Quarter?

    Cullinan Therapeutics, Inc. announced earnings per share of -$0.86 which represents a beat of analyst forecast a -$0.89 per share.

  • Is Cullinan Therapeutics, Inc. Profitable?

    Cullinan Therapeutics, Inc. reported -$79K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Cullinan Therapeutics, Inc. EPS Next Year?

    Cullinan Therapeutics, Inc.'s earnings are forecast to decrease from -$3.11 per share to -$2.94 per share next year representing a decrease of -13.34%.

  • When is Cullinan Therapeutics, Inc.'s Earnings Date?

    Cullinan Therapeutics, Inc.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
57
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
1
LW alert for Dec 22

Lamb Weston Holdings, Inc. [LW] is down 2.59% over the past day.

Buy
54
BMRN alert for Dec 22

BioMarin Pharmaceutical, Inc. [BMRN] is down 3.03% over the past day.

Buy
82
RKLB alert for Dec 22

Rocket Lab Corp. [RKLB] is up 9.97% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock